MALARIA,FALCIPARUM
Clinical trials for MALARIA,FALCIPARUM explained in plain language.
Never miss a new study
Get alerted when new MALARIA,FALCIPARUM trials appear
Sign up with your email to follow new studies for MALARIA,FALCIPARUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new malaria vaccine trial begins in burkina faso
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new malaria vaccine designed to target the parasite at multiple stages of its life cycle. It involves 56 healthy adults (18-35 years) and children (5-17 months) in Burkina Faso. The main goal is to check the vaccine's safety and how well it triggers an immune r…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:03 UTC
-
New malaria vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new malaria vaccine (PfSPZ-LARC2) in 58 healthy adults who have never had malaria. The vaccine uses weakened malaria parasites that stop growing in the liver and cannot cause blood infection. Researchers will check if it is safe and if it protects against malar…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:49 UTC
-
Blood test could unlock Malaria's secret hiding spots
Disease control Recruiting nowThis study tests a new approach to fight a type of malaria (P. vivax) that can hide in the liver and come back months later. Researchers will use a simple blood test to find people who have been infected recently, then give them a treatment to clear the hidden parasites. The goal…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New malaria drug candidate enters first human safety tests
Disease control Recruiting nowThis study is the first time a new experimental malaria drug, GSK4024484, is being tested in humans. The main goal is to see if it is safe for healthy adults and how the body processes it. Researchers will also check if taking the pill with food changes its effects. The study inv…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Could mass drug administration wipe out malaria in ghanaian communities?
Disease control Recruiting nowThis study aims to see if giving a combination of malaria drugs (DHAP and primaquine) to everyone in high-risk communities can reduce malaria infections and stop the disease from spreading. About 9,000 people aged 3 months and older will receive the drugs every two months for a y…
Matched conditions: MALARIA,FALCIPARUM
Phase: NA • Sponsor: Noguchi Memorial Institute for Medical Research • Aim: Disease control
Last updated May 15, 2026 11:53 UTC